CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 111 filers reported holding CLOVIS ONCOLOGY INC in Q4 2013. The put-call ratio across all filers is 0.91 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $723,000 | -78.6% | 48,598 | +32.5% | 0.00% | -90.0% |
| Q3 2015 | $3,373,000 | +68.3% | 36,683 | +60.8% | 0.01% | +100.0% |
| Q2 2015 | $2,004,000 | +49.4% | 22,806 | +26.2% | 0.01% | +25.0% |
| Q1 2015 | $1,341,000 | +3.2% | 18,065 | -3.6% | 0.00% | -33.3% |
| Q1 2014 | $1,299,000 | +83.7% | 18,749 | +59.7% | 0.01% | +100.0% |
| Q4 2013 | $707,000 | +96.4% | 11,737 | +98.4% | 0.00% | +50.0% |
| Q3 2013 | $360,000 | +58.6% | 5,917 | +74.6% | 0.00% | +100.0% |
| Q2 2013 | $227,000 | – | 3,389 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 250,000 | $1,200,000 | 4.04% |
| Palo Alto Investors LP | 4,469,411 | $21,453,000 | 1.12% |
| ARMISTICE CAPITAL, LLC | 2,256,000 | $10,829,000 | 0.37% |
| Vigilare Wealth Management | 32,200 | $155,000 | 0.15% |
| Ikarian Capital, LLC | 650,000 | $3,121,000 | 0.14% |
| Ikarian Capital, LLC | 642,108 | $3,082,000 | 0.14% |
| WELD CAPITAL MANAGEMENT LLC | 40,156 | $193,000 | 0.08% |
| PINNACLE ASSOCIATES LTD | 703,970 | $3,379,000 | 0.07% |
| Versant Venture Management, LLC | 101,855 | $489,000 | 0.05% |
| Kalos Management, Inc. | 23,750 | $114,000 | 0.05% |